Lack of Benefit of Fluvoxamine for COVID-19

被引：4

作者：

Bhimraj, Adarsh ^{[1
,3
]}

Gallagher, Jason C. ^{[2
]}

机构：

[1] Houston Methodist Hosp, Div Infect Dis, Houston, TX USA

[2] Temple Univ, Dept Pharm Practice, Philadelphia, PA USA

[3] Houston Methodist Hosp, Infect Dis Fellowship & Educ, 6560 Fannin St, Ste 1512, Houston, TX 77030 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 04期

关键词：

D O I：

10.1001/jama.2022.23954

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：291 / 292

页数：2

共 50 条

[1] Fluvoxamine for COVID-19?
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1623): : 69 - 70
[2] Fluvoxamine in COVID-19
Devi, Sharmila
LANCET INFECTIOUS DISEASES, 2024, 24 (01) : E23 - E23
[3] Fluvoxamine for the treatment of COVID-19
Kim, Hyun
Manzi, Shannon
Gonzelez-Heydrich, Joseph
Picker, Jonathan
LANCET GLOBAL HEALTH, 2022, 10 (03): : E330 - E330
[4] Fluvoxamine for the treatment of COVID-19
Nyirenda, John L. Z.
Sofroniou, Mario
Toews, Ingrid
Mikolajewska, Agata
Lehane, Cornelius
Monsef, Ina
Abu-taha, Aesha
Maun, Andy
Stegemann, Miriam
Schmucker, Christine
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
[5] Trial of fluvoxamine in COVID-19
Kang, Seema
LANCET PSYCHIATRY, 2022, 9 (01): : 17 - 17
[6] Fluvoxamine, melatonin and COVID-19
George M. Anderson
Psychopharmacology, 2021, 238 : 611 - 611
[7] Fluvoxamine, melatonin and COVID-19
Anderson, George M.
PSYCHOPHARMACOLOGY, 2021, 238 (02) : 611 - 611
[8] Fluvoxamine for COVID-19 ICU patients?
Trkulja, Vladimir
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2454 - 2455
[9] Fluvoxamine for symptomatic outpatients with COVID-19
Wu, Peter E.
Austin, Emily
Leong, Derek
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (07) : E258 - E258
[10] Repurposing approach of fluvoxamine for COVID-19
McCarthy, M. W.
DRUGS OF THE FUTURE, 2021, 46 (10) : 813 - 818